datma Expands Federated Real-World Data Network Surpassing 1 Million Patient Lives with Multi omic and Pathology Data

BEAVERTON, Ore., March 12, 2025 /PRNewswire/ -- datma, a leader in federated real-world data access, today announced that its federated real-world data marketplace launched in October of 2024 has surpassed one million records available for research. This milestone demonstrates the strength of datma.FED as a leading platform for secure, federated access to high-quality, demographic, EHR, genomic, and pathology data, providing pharmaceutical and research organizations with critical insights often missing from traditional real-world data sources.

With the expansion of datma.FED, pharmaceutical and research organizations gain scalable access to contextual and longitudinal genomic and pathology insights. Unlike traditional data models that require data transfers or centralized repositories, datma.FED enables secure, federated queries, ensuring that data custodians retain full control over their datasets while providing pharmaceutical researchers access to real-world oncology data. 

"This milestone significantly expands the depth and quality of real-world genomic data available within datma.FED," said Noah Nasser, CEO at datma. "With over one million patient lives now available, researchers and pharmaceutical teams can gain deeper insights into real-world data and explore patterns in genomic testing utilization- while ensuring the highest privacy and data stewardship standards. By connecting the right data with the right researchers, we are accelerating discovery without the risks and challenges of traditional data-sharing models."

The integration of specialized molecular profiling and comprehensive genomic datasets fills a critical gap in pharma's existing real-world datasets. While claims and EHR data provide insight into diagnoses and treatments, they often lack molecular testing details. By incorporating genomic and pathology data, pharma can now assess biomarker prevalence, evaluate molecular testing utilization trends, and identify gaps in testing uptake. These insights help pharma teams refine market access strategies and drive more informed commercialization efforts.

datma.FED's federated model ensures compliance with HIPAA and regulatory standards while eliminating the burdens of manual data preparation and integration. The platform ingests, standardizes, and harmonizes healthcare data, making research-ready data immediately queryable for pharmaceutical and research teams. As datma continues to expand its network, it remains focused on bridging the gap between real-world data and its application in research and discovery in precision medicine.

About datma
datma is a leading provider of federated Real-World Data platform and related tools for analysis and visualization. datma's mission is to empower healthcare organizations to optimize their data assets, drive innovation, and improve patient outcomes through advanced data storage, AI-enabled data harmonization, and federated query and workflow technology. Headquartered in Oregon, the company is at the forefront of transforming how healthcare data is shared, monetized, and applied by enabling secure collaboration between data custodians and data consumers. By facilitating the analysis of rich, decentralized datasets without compromising privacy, datma enables health systems and reference laboratories to create secondary revenue streams and invest in innovation, while empowering data consumers with insights that may lead to new discoveries, greater access, and enhance clinical practice. For more information, visit www.datma.com

Media Contact:
Vikki Herrera
Oak Street Communications
[email protected]

SOURCE datma, Inc